US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

FibroBiologics

1.38

+0.190015.97%

Volume:506.40K

Turnover:668.83K

Market Cap:52.07M

PE:-4.06

High:1.44

Open:1.22

Low:1.15

Close:1.19

Loading ...

Overview Company News Filings

Fibrobiologics and Charles River Announce Completion and Release of Cywc628 Master Cell Bank for the Manufacturing of Fibroblast Cell-Based Wound Healing Therapeutic

THOMSON REUTERS

FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic

FBLG: Analyst Day Provides In-Depth Overview of Pipeline…

Zacks Small Cap Research

FibroBiologics Is Maintained at Buy by D. Boral Capital

Fibrobiologics to Host in-Person Analyst Day to Provide Research & Development Updates

THOMSON REUTERS

FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates

FibroBiologics And 2 Other US Penny Stocks To Watch

Simply Wall St.

FibroBiologics files $50M mixed securities shelf

Fibrobiologics Inc Files for Mixed Shelf of up to $50 Mln - SEC Filing

THOMSON REUTERS

FibroBiologics Approves Executive Bonuses for 2024

FibroBiologics Secures $5M Funding for Strategic Growth

FibroBiologics Closes Second $5 Million Tranche of $25 Million Equity Purchase Agreement

MT Newswires Live

BRIEF-Fibrobiologics Closes Second $5 Mln Tranche Of $25 Mln Financing

Fibrobiologics Closes Second $5 Million Tranche of $25 Million Financing

THOMSON REUTERS

D. Boral Capital Served as Exclusive Placement Agent to Fibrobiologics, Inc. (Nasdaq: Fblg) in Connection With Its $25.0 Million Financing

THOMSON REUTERS

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

FibroBiologics Files Secondary Stock Shelf

MT Newswires Live

FibroBiologics files to sell 41.3M shares of common stock for holders

Fibrobiologics Inc: Files for Resale of up to 41.3 Mln Shares of Common Stock by Selling Stockholder - SEC Filing

THOMSON REUTERS

FibroBiologics Obtains up to $25 Million Financing

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FBLG/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FBLG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","market":"US","secType":"STK","nameCN":"FibroBiologics","latestPrice":1.38,"timestamp":1745265600000,"preClose":1.19,"halted":0,"volume":506399,"delay":0,"floatShares":27939955,"shares":37735300,"eps":-0.339497,"marketStatus":"Pre-Mkt","change":0.19,"latestTime":"04-22 07:18:22 EDT","open":1.22,"high":1.44,"low":1.15,"amount":668831.6951597,"amplitude":0.243697,"askPrice":1.5,"askSize":1400,"bidPrice":1.4,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-0.339497,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":0,"listingDate":1706677200000,"exchange":"NASDAQ","adjPreClose":1.38,"postHourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.38,"latestTime":"19:58 EDT","volume":15889,"amount":21955.2327,"timestamp":1745279922641},"volumeRatio":1.683238712355273},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","floatShares":27939955,"roa":"-60.75%","roe":"-559.73%","lyrEps":-0.339497,"volumeRatio":1.683238712355273,"shares":37735300,"dividePrice":0,"high":1.44,"amplitude":0.243697,"preClose":1.19,"low":1.15,"week52Low":0.7626,"pbRate":"19.04","week52High":13.59,"institutionHeld":0,"latestPrice":1.38,"committee":-0.998572,"eps":-0.339497,"divideRate":0,"volume":506399,"delay":0,"ttmEps":-0.339497,"open":1.22,"prevYearClose":2,"prevWeekClose":1.19,"prevMonthClose":0.9,"prevQuarterClose":0.9,"fiveDayClose":0.89,"twentyDayClose":1.11,"sixtyDayClose":1.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBLG\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514980244","title":"Fibrobiologics and Charles River Announce Completion and Release of Cywc628 Master Cell Bank for the Manufacturing of Fibroblast Cell-Based Wound Healing Therapeutic","url":"https://stock-news.laohu8.com/highlight/detail?id=2514980244","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514980244?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:30","pubTimestamp":1740663007,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nFWN3PI1BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0390134368.USD","BK4588","FBLG","BK4121","CRL","BK4530","BK4585","BK4139"],"gpt_icon":0},{"id":"2514071518","title":"FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic","url":"https://stock-news.laohu8.com/highlight/detail?id=2514071518","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514071518?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:30","pubTimestamp":1740663000,"startTime":"0","endTime":"0","summary":"Master cell bank to be used in manufacturing of CYWC628 drug product to support upcoming clinical trial for diabetic foot ulcersHOUSTON, Feb.  27, 2025  (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasd","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3033859/0/en/FibroBiologics-and-Charles-River-Announce-Completion-and-Release-of-CYWC628-Master-Cell-Bank-for-the-Manufacturing-of-Fibroblast-Cell-based-Wound-Healing-Therapeutic.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2514771408","title":"FBLG: Analyst Day Provides In-Depth Overview of Pipeline…","url":"https://stock-news.laohu8.com/highlight/detail?id=2514771408","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514771408?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:31","pubTimestamp":1740400260,"startTime":"0","endTime":"0","summary":"On February 12, 2025, Fibrobiologics, Inc.  held an Analyst Day and provided a comprehensive update on the company and its fibroblast-based development products. The presentation can be viewed here. The company is currently focused on a number of different therapeutic areas, including diabetic foot ulcers, multiple sclerosis, and psoriasis along with early-stage research in thymus regeneration, cancer, and pancreatic organoid.CYWC628: This is being developed for the treatment of diabetic foot ulcers , which cause significant morbidity for the 6.3% of diabetic adults  that develop them. Of those, 20% will require lower extremity amputation and 10% will die within the first year of their first DFU. In addition, once a DFU forms there is a high rate of recurrence, both at one year (40%) and three years (70%).Fibroblasts have excellent therapeutic potential in the treatment of DFUs due to the critical role they play in every stage of wound healing, including hemostasis, inflammation, proli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fblg-analyst-day-provides-depth-123100862.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0006306889.USD","LU0158827781.USD","LU0158827948.USD","FBLG","LU0795875169.SGD","LU0795875086.SGD","BK4197","BK4127","LU0971096721.USD","BK4516","LU1162221912.USD","LU2111349929.HKD","BK4139","LU1732800096.USD","LU0912757837.SGD","LU0106261372.USD","BK4534","LU1732799900.SGD","LU1074936037.SGD","LU1668664300.SGD","ATO","LU1363072403.SGD","IE00BZ1G4Q59.USD","BK4504","LU1989772923.USD","IE00BKVL7J92.USD","LU2271345857.HKD","LU0106831901.USD","LU1989772840.SGD","BK4588","BK4585","SEPA","LU2028103732.USD","BK4581","LU2089284900.SGD","LU2089283258.USD","LU2133065610.SGD","LU0267386448.USD","LU2023251221.USD","LU0225283273.USD","LU0098860793.USD","LU1720051108.HKD","LU0314104364.USD","LU2347655156.SGD","LU0320765646.SGD","LU1548497426.USD","LU1720051017.SGD","LU2357305700.SGD"],"gpt_icon":0},{"id":"2511457642","title":"FibroBiologics Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2511457642","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511457642?lang=en_us&edition=fundamental","pubTime":"2025-02-14 02:10","pubTimestamp":1739470200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FBLG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 13, 2025 13:10 ET (18:10 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG"],"gpt_icon":0},{"id":"2509328115","title":"Fibrobiologics to Host in-Person Analyst Day to Provide Research & Development Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2509328115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509328115?lang=en_us&edition=fundamental","pubTime":"2025-02-05 22:15","pubTimestamp":1738764900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nTUA58RDJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2509200281","title":"FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2509200281","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509200281?lang=en_us&edition=fundamental","pubTime":"2025-02-05 22:15","pubTimestamp":1738764900,"startTime":"0","endTime":"0","summary":"FibroBiologics to also present at the BIO CEO & Investor Conference. HOUSTON, Feb. 05, 2025  -- FibroBiologics, Inc.  , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that it will host an in-person analyst day at the New York Marriott Marquis on February 12, 2025, at 2:00 p.m. ET.The event will feature presentations from the following members of the Company's management:. The event will highlight FibroBiologics’ research and development strategy for advancing fibroblast-based therapeutics to address chronic diseases.A live Q&A session will follow the formal presentations. An audio recording of the presentation and Q&A will be available under the investor section of the FibroBiologics website after the event.In addition, FibroBiologics will be presenting at the 2025 BIO CEO & Investor Conference in New York, N","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fibrobiologics-host-person-analyst-day-141500050.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4588","BK4181","FBLG","BK4218","BK4139","HST"],"gpt_icon":0},{"id":"2509995694","title":"FibroBiologics And 2 Other US Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2509995694","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509995694?lang=en_us&edition=fundamental","pubTime":"2025-02-05 04:06","pubTimestamp":1738699589,"startTime":"0","endTime":"0","summary":"As the U.S. stock market reacts to recent developments in tariffs and corporate earnings, investors are on the lookout for opportunities that may not be immediately apparent in larger indices. Penny stocks, a term often associated with speculative investments, represent an intriguing segment of the market where smaller or newer companies can offer potential growth at accessible price points. Despite their vintage label, these stocks can provide substantial value when backed by strong financials and fundamentals, making them worthy of attention for those seeking hidden gems in today's economic landscape.Overview: FibroBiologics, Inc. is a cell therapy and regenerative medicine company with a market cap of $56.49 million.Operations: FibroBiologics, Inc. currently does not report any revenue segments.Click to explore a detailed breakdown of our findings in FibroBiologics' financial health report.Understand FibroBiologics' earnings outlook by examining our growth report.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fibrobiologics-2-other-us-penny-200629672.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4209","BK4213","FBLG","PVL","SDCH","SYPR","BK4023","BK4139","BABB"],"gpt_icon":0},{"id":"2508469931","title":"FibroBiologics files $50M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2508469931","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508469931?lang=en_us&edition=fundamental","pubTime":"2025-02-03 22:25","pubTimestamp":1738592737,"startTime":"0","endTime":"0","summary":"09:23 EST FibroBiologics (FBLG) files $50M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fibrobiologics-files-50m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fibrobiologics-files-50m-mixed-securities-shelf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2508377146","title":"Fibrobiologics Inc Files for Mixed Shelf of up to $50 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2508377146","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508377146?lang=en_us&edition=fundamental","pubTime":"2025-02-03 22:20","pubTimestamp":1738592436,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250203:nFWN3OU0TI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2506815917","title":"FibroBiologics Approves Executive Bonuses for 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2506815917","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506815917?lang=en_us&edition=fundamental","pubTime":"2025-01-25 05:31","pubTimestamp":1737754266,"startTime":"0","endTime":"0","summary":"FibroBiologics, Inc. ( ($FBLG) ) has provided an update. On January 23, 2025, FibroBiologics, Inc. announced that its Compensation Committee and Bo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-approves-executive-bonuses-for-2024?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-approves-executive-bonuses-for-2024?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2500462319","title":"FibroBiologics Secures $5M Funding for Strategic Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2500462319","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500462319?lang=en_us&edition=fundamental","pubTime":"2025-01-01 05:47","pubTimestamp":1735681663,"startTime":"0","endTime":"0","summary":"FibroBiologics, Inc. ( ($FBLG) ) has issued an announcement. FibroBiologics, Inc. announced the closure of the second $5 million tranche under the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-secures-5m-funding-for-strategic-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fibrobiologics-secures-5m-funding-for-strategic-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2495662667","title":"FibroBiologics Closes Second $5 Million Tranche of $25 Million Equity Purchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2495662667","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495662667?lang=en_us&edition=fundamental","pubTime":"2024-12-31 18:12","pubTimestamp":1735639948,"startTime":"0","endTime":"0","summary":"FibroBiologics  said late Monday it has closed the second $5 million tranche of its standby equity purchase agreement with YA II PN, an investment fund managed by Yorkville Advisors Global.The biotech company said it expects to use net proceeds from the financing tranche for general corporate purposes.The equity purchase agreement lets FibroBiologics sell up to $25 million of its shares to Yorkville over two years, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4215","BK4585","BK4139","EQR","BK4588","FBLG"],"gpt_icon":0},{"id":"2495505629","title":"BRIEF-Fibrobiologics Closes Second $5 Mln Tranche Of $25 Mln Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2495505629","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495505629?lang=en_us&edition=fundamental","pubTime":"2024-12-31 05:35","pubTimestamp":1735594532,"startTime":"0","endTime":"0","summary":"BRIEF-Fibrobiologics Closes Second $5 Mln Tranche Of $25 Mln FinancingDec 30 (Reuters) - Fibrobiologics Inc FBLG.O:FIBROBIOLOGICS CLOSES SECOND $5 MILLION TRANCHE OF $25 MILLION FINANCINGSource text: ID:nGNX3wQ63zFurther company coverage: FBLG.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA91SQMH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2495505361","title":"Fibrobiologics Closes Second $5 Million Tranche of $25 Million Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2495505361","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495505361?lang=en_us&edition=fundamental","pubTime":"2024-12-31 05:30","pubTimestamp":1735594200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA91SQMH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2495574531","title":"D. Boral Capital Served as Exclusive Placement Agent to Fibrobiologics, Inc. (Nasdaq: Fblg) in Connection With Its $25.0 Million Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2495574531","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495574531?lang=en_us&edition=fundamental","pubTime":"2024-12-31 03:13","pubTimestamp":1735585987,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nTUA2CF5CP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IE00BKPKM429.USD","FBLG","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","NDAQ","BK4585","BK4588","LU2210149790.SGD","BK4112"],"gpt_icon":0},{"id":"2495572123","title":"D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2495572123","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495572123?lang=en_us&edition=fundamental","pubTime":"2024-12-31 03:12","pubTimestamp":1735585920,"startTime":"0","endTime":"0","summary":"HOUSTON, Dec. 30, 2024  -- FibroBiologics, Inc.  , a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that it has entered into a Standby Equity Purchase Agreement  with YA II PN LTD. , an investment fund managed by Yorkville Advisors Global, LP. The agreement allows FibroBiologics, subject to customary conditions, to sell up to $25 million in the aggregate of its common stock to Yorkville over the course of two years.This communication contains \"forward-looking statements\" as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning the funding of the advances under the SEPA, FibroBiologics’ ability to sell additional shares under the SEPA, and FibroBiolo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/d-boral-capital-served-exclusive-191200791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","QLD","BK4112","USAW.SI","FBLG","IE00BGHQF748.EUR","PSQ","BK4585","IE00BKPKM429.USD","USJW.SI","TSYW.SI","BK4588","NQmain",".IXIC","BK4139","LU2210149790.SGD","NDAQ","MNQmain","IE00B64PRP62.GBP","TQQQ","NVIW.SI","SQQQ","IE00B3QW5Z07.USD","QID","LU2210150020.SGD"],"gpt_icon":1},{"id":"2495874525","title":"FibroBiologics Files Secondary Stock Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2495874525","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495874525?lang=en_us&edition=fundamental","pubTime":"2024-12-30 22:51","pubTimestamp":1735570299,"startTime":"0","endTime":"0","summary":"FibroBiologics (FBLG) filed a registration statement Monday covering the potential resale of up to about 41.3 million of its shares from time to time by a selling stockholder.The company said it will ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2495523884","title":"FibroBiologics files to sell 41.3M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2495523884","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495523884?lang=en_us&edition=fundamental","pubTime":"2024-12-30 22:20","pubTimestamp":1735568407,"startTime":"0","endTime":"0","summary":"09:20 EST FibroBiologics (FBLG) files to sell 41.3M shares of common stock for holders Published first on TheFly – the ultimate source for real-tim...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/fibrobiologics-files-to-sell-41-3m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/fibrobiologics-files-to-sell-41-3m-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2495542613","title":"Fibrobiologics Inc: Files for Resale of up to 41.3 Mln Shares of Common Stock by Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2495542613","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495542613?lang=en_us&edition=fundamental","pubTime":"2024-12-30 21:33","pubTimestamp":1735565613,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nFWN3NS05C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2493397762","title":"FibroBiologics Obtains up to $25 Million Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2493397762","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493397762?lang=en_us&edition=fundamental","pubTime":"2024-12-23 23:50","pubTimestamp":1734969006,"startTime":"0","endTime":"0","summary":"FibroBiologics  said Monday it entered into a standby equity purchase agreement allowing it to sell up to $25 million of its common stock over two years to an investment fund managed by Yorkville Advisors Global.The first $15 million would be released in three equal tranches to be evidenced by convertible promissory notes, with the first tranche of $5 million funded upon signing of the agreement and the next two tranches to fund following the filing of a registration statement for the resale of the shares issuable to Yorkville, and upon the effectiveness of the registration statement and receipt of shareholder approval, FibroBiologics said.The company said that subject to certain conditions, it can sell $10 million more of its common stock to the fund while the convertible promissory notes remain outstanding.The initial advances will allow FibroBiologics to complete its first-in-human trial for diabetic foot ulcers and investigational new drug-enabling studies for its psoriasis program","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","FBLG"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":71,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBLG\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBLG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBLG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1730520000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FBLG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FBLG","date":"2025-04-21","current":-4.023386,"percent":0.680702,"low":-68.573467,"twenty":-19.61153,"median":-5.267231,"eighty":-3.105834,"high":-1.984604,"avg":-11.019411,"sd":12.208382,"marketCap":44905007},"quantilePoints":[{"date":"2024-02-02","current":-68.573467,"twenty":-68.573467,"median":-68.573467,"eighty":-68.573467,"marketCap":568611190},{"date":"2024-02-09","current":-30.642544,"twenty":-58.777258,"median":-48.452053,"eighty":-34.01244,"marketCap":254087971},{"date":"2024-02-16","current":-50.313332,"twenty":-58.777258,"median":-50.313332,"eighty":-30.642544,"marketCap":417198153},{"date":"2024-02-23","current":-47.413654,"twenty":-56.896385,"median":-48.5892,"eighty":-33.338461,"marketCap":393154022},{"date":"2024-03-01","current":-25.741365,"twenty":-54.984165,"median":-48.491237,"eighty":-33.338461,"marketCap":424346408},{"date":"2024-03-08","current":-19.47356,"twenty":-53.244359,"median":-47.492024,"eighty":-25.717713,"marketCap":321021631},{"date":"2024-03-15","current":-20.892685,"twenty":-51.363486,"median":-37.245189,"eighty":-20.955758,"marketCap":344415920},{"date":"2024-03-22","current":-23.849198,"twenty":-50.446561,"median":-28.99678,"eighty":-20.813845,"marketCap":393154022},{"date":"2024-03-28","current":-23.159345,"twenty":-50.219289,"median":-25.741365,"eighty":-20.93999,"marketCap":381781799},{"date":"2024-04-05","current":-22.469492,"twenty":-49.216157,"median":-24.637601,"eighty":-21.160743,"marketCap":370409575},{"date":"2024-04-12","current":-22.311811,"twenty":-48.471645,"median":-23.652097,"eighty":-21.298713,"marketCap":367810209},{"date":"2024-04-19","current":-21.700799,"twenty":-48.064123,"median":-23.20862,"eighty":-21.030656,"marketCap":357737668},{"date":"2024-04-26","current":-23.021374,"twenty":-47.63309,"median":-22.804563,"eighty":-21.030656,"marketCap":379507354},{"date":"2024-05-03","current":-13.245174,"twenty":-47.445002,"median":-22.479347,"eighty":-20.675875,"marketCap":218346696},{"date":"2024-05-10","current":-17.22661,"twenty":-43.252224,"median":-22.05558,"eighty":-19.871704,"marketCap":283980674},{"date":"2024-05-17","current":-17.017594,"twenty":-36.598639,"median":-21.769784,"eighty":-19.221271,"marketCap":383406402},{"date":"2024-05-24","current":-16.310932,"twenty":-31.990502,"median":-21.661379,"eighty":-18.255477,"marketCap":367485289},{"date":"2024-05-31","current":-17.767522,"twenty":-29.984238,"median":-21.543118,"eighty":-17.827098,"marketCap":400302277},{"date":"2024-06-07","current":-14.972667,"twenty":-28.19741,"median":-21.306597,"eighty":-17.252609,"marketCap":337334178},{"date":"2024-06-14","current":-10.427133,"twenty":-26.746956,"median":-21.178482,"eighty":-16.659936,"marketCap":234923317},{"date":"2024-06-21","current":-7.769521,"twenty":-25.741365,"median":-20.932105,"eighty":-16.368618,"marketCap":175047318},{"date":"2024-06-28","current":-6.767471,"twenty":-25.694061,"median":-20.88283,"eighty":-16.302279,"marketCap":152471122},{"date":"2024-07-05","current":-6.143005,"twenty":-25.43783,"median":-20.64631,"eighty":-15.81876,"marketCap":138401898},{"date":"2024-07-12","current":-7.689204,"twenty":-24.673079,"median":-20.183123,"eighty":-14.136173,"marketCap":173237756},{"date":"2024-07-15","current":-7.514809,"twenty":-24.649427,"median":-20.094427,"eighty":-13.517924,"marketCap":169308652},{"date":"2024-08-02","current":-7.974576,"twenty":-24.625775,"median":-20.005732,"eighty":-13.175194,"marketCap":179667198},{"date":"2024-08-09","current":-4.080921,"twenty":-24.140907,"median":-19.700225,"eighty":-10.836667,"marketCap":79459622},{"date":"2024-08-16","current":-2.166861,"twenty":-23.730937,"median":-18.842837,"eighty":-9.439605,"marketCap":42190950},{"date":"2024-08-23","current":-2.546062,"twenty":-23.640271,"median":-18.638558,"eighty":-7.79743,"marketCap":49574366},{"date":"2024-08-30","current":-2.915474,"twenty":-23.407692,"median":-18.172694,"eighty":-7.552859,"marketCap":56767191},{"date":"2024-09-06","current":-3.368187,"twenty":-23.218475,"median":-17.767522,"eighty":-6.924314,"marketCap":65581972},{"date":"2024-09-13","current":-5.722296,"twenty":-23.104157,"median":-17.428613,"eighty":-6.143005,"marketCap":111418835},{"date":"2024-09-20","current":-5.722296,"twenty":-22.93465,"median":-17.22661,"eighty":-5.90745,"marketCap":111418835},{"date":"2024-09-27","current":-5.686079,"twenty":-22.765143,"median":-16.563311,"eighty":-5.873037,"marketCap":110713652},{"date":"2024-10-04","current":-4.798761,"twenty":-22.619289,"median":-16.368618,"eighty":-5.722296,"marketCap":93436681},{"date":"2024-10-11","current":-4.20118,"twenty":-22.481318,"median":-16.080185,"eighty":-5.265962,"marketCap":81801170},{"date":"2024-10-18","current":-6.012033,"twenty":-22.40642,"median":-15.807485,"eighty":-5.066768,"marketCap":117060295},{"date":"2024-10-25","current":-5.215258,"twenty":-22.209319,"median":-15.237992,"eighty":-5.131958,"marketCap":101546280},{"date":"2024-10-31","current":-5.342017,"twenty":-22.020102,"median":-13.586112,"eighty":-5.110228,"marketCap":104014418},{"date":"2024-11-08","current":-6.464746,"twenty":-21.866364,"median":-12.649071,"eighty":-5.128337,"marketCap":125875076},{"date":"2024-11-15","current":-5.477931,"twenty":-21.799349,"median":-10.768411,"eighty":-5.146445,"marketCap":97392141},{"date":"2024-11-22","current":-4.698155,"twenty":-21.716567,"median":-9.773622,"eighty":-5.018763,"marketCap":83528491},{"date":"2024-11-29","current":-5.107537,"twenty":-21.700799,"median":-9.003931,"eighty":-5.016064,"marketCap":90806907},{"date":"2024-12-06","current":-4.639671,"twenty":-21.661379,"median":-7.895306,"eighty":-4.997955,"marketCap":82488717},{"date":"2024-12-13","current":-4.425233,"twenty":-21.562828,"median":-7.720912,"eighty":-4.979847,"marketCap":78676213},{"date":"2024-12-20","current":-3.957367,"twenty":-21.543118,"median":-7.546517,"eighty":-4.853087,"marketCap":70358023},{"date":"2024-12-27","current":-4.50321,"twenty":-21.511582,"median":-7.203145,"eighty":-4.778145,"marketCap":80062578},{"date":"2025-01-03","current":-3.869642,"twenty":-21.385437,"median":-6.905845,"eighty":-4.698155,"marketCap":68798363},{"date":"2025-01-10","current":-4.065278,"twenty":-21.306597,"median":-6.609614,"eighty":-4.652603,"marketCap":72276579},{"date":"2025-01-17","current":-3.769263,"twenty":-21.298713,"median":-6.286711,"eighty":-4.50321,"marketCap":67013721},{"date":"2025-01-24","current":-3.157497,"twenty":-21.243525,"median":-6.193118,"eighty":-4.433031,"marketCap":56137148},{"date":"2025-01-31","current":-3.295638,"twenty":-21.050366,"median":-6.140899,"eighty":-4.36675,"marketCap":58593149},{"date":"2025-02-07","current":-3.157497,"twenty":-20.955758,"median":-6.004281,"eighty":-4.203103,"marketCap":56137148},{"date":"2025-02-14","current":-2.545732,"twenty":-20.888743,"median":-5.948653,"eighty":-4.068407,"marketCap":45260576},{"date":"2025-02-21","current":-2.447061,"twenty":-20.872975,"median":-5.908467,"eighty":-3.946872,"marketCap":43506290},{"date":"2025-02-28","current":-2.348389,"twenty":-20.794135,"median":-5.885273,"eighty":-3.784683,"marketCap":41752004},{"date":"2025-03-07","current":-2.210248,"twenty":-20.498484,"median":-5.867165,"eighty":-3.670591,"marketCap":39296004},{"date":"2025-03-14","current":-2.109947,"twenty":-20.183123,"median":-5.776622,"eighty":-3.453513,"marketCap":37512750},{"date":"2025-03-21","current":-2.151728,"twenty":-20.183123,"median":-5.722296,"eighty":-3.368187,"marketCap":38255577},{"date":"2025-03-28","current":-2.130838,"twenty":-20.005732,"median":-5.595537,"eighty":-3.295638,"marketCap":37884163},{"date":"2025-04-04","current":-2.958372,"twenty":-19.926892,"median":-5.518575,"eighty":-3.165965,"marketCap":33018387},{"date":"2025-04-11","current":-2.748074,"twenty":-19.788921,"median":-5.342017,"eighty":-3.105834,"marketCap":30671251},{"date":"2025-04-17","current":-3.685286,"twenty":-19.647008,"median":-5.282987,"eighty":-3.104326,"marketCap":41131477},{"date":"2025-04-21","current":-4.023386,"twenty":-19.61153,"median":-5.267231,"eighty":-3.105834,"marketCap":44905007}],"updateTime":1745320702429}}}